Pharma News, 2022

New Delhi: India’s Gennova Biopharmaceuticals is working on an omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told...

Indian generic drugmaker Marksans Pharma has won FDA approval for its cetirizine hydrochloride tablets.

A research effort led by Stanford scientists set the first Guinness World Record for the fastest DNA sequencing technique, which was used to sequence a human genome in just 5 hours and 2 minutes. ...

The virus that causes herpes is likely the main cause of multiple sclerosis (MS), a groundbreaking study has suggested.

A new study published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy has shown that isolated cannabinoids or those in hemp extracts have t...

Tempol is being analysed in a double-blind, randomised, adaptive, Phase II/II clinical trial for Covid-19 treatment.

The FDA approved many new drugs and technologies over the past year, and in the dermatology world those approvals included treatments for a multitude of conditions. ...

Alembic Pharmaceuticals has gotten tentative approval for its abbreviated new drug application (ANDA) for dronedarone, a generic equivalent to Sanofi-Aventis’ anti-arrhythmic Multaq, which the FD...

In a medical first, doctors transplanted a pig heart into a patient in a last-ditch effort to save his life and a Maryland hospital said Monday that he’s doing well three days after the highly e...

Using two different free protein-predicting AI algorithms, computer scientists were almost able to model Omicron before the coronavirus variant had been physically mapped. ...

The future of Aduhelm, Biogen Inc's (BIIB.O) controversial and expensive Alzheimer's drug, may hinge on a decision due this week from the U.S. Medicare program on whether it will pay for the treatm...

Amgen’s Lumykras (sotorasib) — branded as Lumakras in the U.S. — has won conditional marketing approval in Europe for treating adults with KRAS G12C-mutated nonsmall-cell lung cancer (NSCLC) ...